MRK Stock MRK is expected to report earnings to rise+6333% to $1.93 per share on April 25

A.I.dvisor
at Tickeron.com
04/24/24
Loading...
MRK - Merck & Co
Merck & Co Earnings Graph
Q1'24
Est.
$1.93
Q4'23
Beat
by $0.14
Q3'23
Beat
by $0.18
Q2'23
Beat
by $0.12
Q1'23
Beat
by $0.05
The last earnings report on December 31 showed earnings per share of 3 cents, beating the estimate of -11 cents. P/B Ratio (8.826) is normal, around the industry mean (5.632). MRK's P/E Ratio (935.643) is considerably higher than the industry average of (48.974). Projected Growth (PEG Ratio) (0.105) is also within normal values, averaging (3.004). Dividend Yield (0.023) settles around the average of (0.164) among similar stocks. P/S Ratio (5.549) is also within normal values, averaging (3.643). With 7.74M shares outstanding, the current market capitalization sits at 331.75B.
View a ticker or compare two or three
MRKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of human and animal health products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
126 East Lincoln Avenue
Phone
+1 908 740-4000
Employees
72000
Web
https://www.merck.com